12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the pre-market movements of 12 health care stocks on Tuesday. Notable gainers include Biodexa Pharmaceuticals (BDRX), Durect (DRRX), Larimar Therapeutics (LRMR), Tevogen Bio Holdings (TVGN), Envoy Medical (COCH), and Citius Pharma (CTXR). Significant losers include Scorpius Holdings (SCPX), Orgenesis (ORGS), SINTX Techs (SINT), Kazia Therapeutics (KZIA), NovaBay Pharmaceuticals (NBY), and Akanda (AKAN).
May 21, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Akanda stock declined by 12.12% to $0.12 in pre-market trading, lowering its market value.
The drop in stock price suggests negative market sentiment and potential for short-term losses.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Kazia Therapeutics stock fell 15.28% to $0.23 in pre-market trading, lowering its market value.
The drop in stock price suggests negative market sentiment and potential for short-term losses.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
NovaBay Pharmaceuticals shares decreased by 13.77% to $0.15 in pre-market trading, reducing its market value.
The decline in share price indicates negative market sentiment and potential for short-term losses.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Orgenesis stock decreased by 16.31% to $0.46 in pre-market trading, lowering its market value.
The drop in stock price suggests negative market sentiment and potential for short-term losses.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Scorpius Holdings stock decreased by 21.9% to $0.12 in pre-market trading, reducing its market value.
The significant drop in stock price indicates negative market sentiment and potential for short-term losses.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
SINTX Techs stock decreased by 15.68% to $0.1 in pre-market trading, reducing its market value.
The decline in stock price indicates negative market sentiment and potential for short-term losses.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Biodexa Pharmaceuticals shares surged by 67.7% to $2.13 in pre-market trading, significantly increasing its market value.
The significant increase in share price indicates strong positive sentiment and potential investor interest.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Envoy Medical shares rose 14.81% to $3.72 in pre-market trading, following the release of its Q1 earnings report.
The increase in share price following the Q1 earnings report indicates positive investor reaction to the company's financial performance.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Citius Pharma shares increased by 14.62% to $0.76 in pre-market trading, boosting its market value.
The rise in share price suggests positive market sentiment and potential for short-term gains.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Durect stock rose 23.07% to $1.28 in pre-market trading, boosting its market value.
The notable rise in stock price suggests positive market sentiment and potential for short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Larimar Therapeutics stock increased by 17.33% to $8.53 in pre-market trading, enhancing its market value.
The rise in stock price indicates positive investor sentiment and potential for short-term appreciation.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Tevogen Bio Holdings shares moved up by 16.64% to $0.91 in pre-market trading, increasing its market value.
The upward movement in share price suggests positive market sentiment and potential for short-term gains.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100